Name

CTCb

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for CTCb

Name

Alternate Names

Oncotepa
Oncotiotepa
Tepa
Tespa
Tespa-min
Tespamine
Thio
Thio-tepa
Thiofozil
Thiophosphamide
Thioplex
Thiotef
Tifosyl
Tio-TEF
Tiofosfamid
Tiofosyl (Sweden)
Tiofozil
Triethylene thiophosphoramide
WR-45312

Abbreviations

STEPA
TESP
TESPA
Thio-TEPA
TSP
TSPA

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

006396
6396

Primary Site

None

Histology

None

Remarks

Cell cycle nonspecific chemotherapeutic agent. FDA approved uses on intravesicular bladder carcinoma, breast adenocarcinoma, malignant intracavitary effusions, Hodgkin's lymphoma, lymphosarcoma, and ovarian adenocarcinoma. Alkylating agent.

Coding

This drug should be coded

Name

Alternate Names

Asta B 518
B-518
Clafen Claphene
Cyclophosphamid
Cyclophosphan
Cyclophosphane
Cytophosphan
Cytoxan
Endoxan
Endoxana
Enduxan
Genoxal
Neosar
Procytox
Sendoxan
Tymtram
WR-138719

Abbreviations

CP
CPM
CTX
CTY
CYC
Cyclo
CYT
CYTOX
CYTX

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

026271
26271

Primary Site

Breast
leukemia
lymphoma
multiple myeloma
neuroblastoma
ovarian cancer
retinoblastoma
soft tissue sarcoma
Wilm's tumor

Histology

None

Remarks

An effective antineoplastic agent and is used for a variety of cancers. FDA approved uses on breast cancer, ovarian carcinoma, leukemia, lymphomas, multiple myeloma, neuroblastma, retinoblastoma, soft tissue sarcoma, Wilm's tumor. Alkylating agent

Coding

This drug should be coded

Name

Alternate Names

JM 8
JM-8
JM8
Paraplatin

Abbreviations

CBDCA

Category

Chemotherapy

Subcategory

Alkylating agent
Platinum analog

NSC Number

241240

Primary Site

All cancers

Histology

None

Remarks

A platinum-salt alkylating agent.

Coding

This drug should be coded
Glossary